Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Baker, Carol J.; Briere, Elizabeth Z.; Clark, Thomas A.; Cohn, Amanda C.; MacNeil, Jessica R.; Meissner, H. Cody; Messonnier, Nancy E.; Ortega-Sanchez, Ismael R.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

March 22, 2013
By Baker, Carol J. ; Briere, Elizabeth Z. ; Clark, Thomas A. ; ...
Series: Morbidity and mortality weekly report. Recommendations and reports, v. 62, no. RR-2

[PDF-25.30 MB]

Select the Download button to view the document

This document is over 5mb in size and cannot be previewed

English

Details Related Documents You May Also Like

Details:

Personal Author:

Baker, Carol J. ; Briere, Elizabeth Z. ; Clark, Thomas A. ; Cohn, Amanda C. ; MacNeil, Jessica R. ; ... More +

Baker, Carol J. ; Briere, Elizabeth Z. ; Clark, Thomas A. ; Cohn, Amanda C. ; MacNeil, Jessica R. ; Meissner, H. Cody ; Messonnier, Nancy E. ; Ortega-Sanchez, Ismael R. Less -
Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases.

United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. Less -
Description:

Meningococcal disease describes the spectrum of infections caused by Neisseria meningiditis, including meningitis, bacteremia, and bacteremia pneumonia. Two quadrivalent meningococcal polysaccharide-protein conjugate vaccines that provide protection against meningococcal serogroups A, C, W, and Y (MenACWY-D [Menactra, manufactured by Sanofi Pasteur, Inc., Swiftwater, Pennsylvania] and MenACWY-CRM [Menveo, manufactured by Novartis Vaccines, Cambridge, Massachusetts]) are licensed in the United States for use among persons aged 2 through 55 years. MenACWY-D also is licensed for use among infants and toddlers aged 9 through 23 months. Quadrivalent meningococcal polysaccharide vaccine (MPSV4 [Menommune, manufactured by sanofi Pasteur, Inc., Swiftwater, Pennsylvania]) is the only vaccine licensed for use among persons aged ?56 years. A bivalent meningococcal polysaccharide protein conjugate vaccine that provides protection against meningococcal serogroups C and Y along with Haemophilus influenzae type b (Hib) (Hib-MenCY-TT [MenHibrix, manufactured by GlaxoSmithKline Biologicals, Rixensart, Belgium]) is licensed for use in children aged 6 weeks through 18 months. This report compiles and summarizes all recommendations from CDC&apos;s Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of meningococcal disease in the United States, specifically the changes in the recommendations published since 2005 (CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2005;54[No. RR-7]). As a comprehensive summary of previously published recommendations, this report does not contain any new recommendations; it is intended for use by clinicians as a resource. ACIP recommends routine vaccination with a quadrivalent meningococcal conjugate vaccine (MenACWY) for adolescents aged 11 or 12 years, with a booster dose at age 16 years. ACIP also recommends routine vaccination for persons at increased risk for meningococcal disease (i.e., persons who have persistent complement component deficiencies, persons who have anatomic or functional asplenia, microbiologists who routinely are exposed to isolates of N. meningitidis, military recruits, and persons who travel to or reside in areas in which meningococcal disease is hyperendemic or epidemic). Guidelines for antimicrobial chemoprophylaxis and for evaluation and management of suspected outbreaks of meningococcal disease also are provided.
Content Notes:

prepared by Amanda C. Cohn, Jessica R. MacNeil, Thomas A. Clark, Ismael R. Ortega-Sanchez, Elizabeth Z. Briere, H. Cody Meissner, Carol J. Baker, Nancy E. Messonnier

March 22, 2013.

The material in this report originated in the National Center for Immunization and Respiratory Diseases, Anne Schuchat, MD, Director, and the Division of Bacterial Diseases, Rana Hajjeh, MD, Director

Also availalble via the World Wide Web.

Includes bibliographical references (p. 19-22).
Subjects:

[+]

Antibiotic Prophylaxis Immunization Schedule Meningococcal Infection Meningococcal Infections Meningococcal Vaccines Students Vaccines, Conjugate
Series:

Morbidity and mortality weekly report. Recommendations and reports, v. 62, no. RR-2 ; MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, no. RR-2

Morbidity and mortality weekly report. Recommendations and reports, v. 62, no. RR-2 ; MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 62, no. RR-2 Less -
Pubmed ID:

28448259
Document Type:

Journal Issue
Genre:

Practice Guideline
Place as Subject:

United States
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Stephen B. Thacker CDC Library collection Morbidity and Mortality Weekly Report (MMWR) Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:e89a3734e15dfbb3cc1ec9c8b053e5dd31b5d478a0f7f588290cb4e003808131
Download URL:

https://stacks.cdc.gov/view/cdc/13320/cdc_13320_DS1.pdf
File Type:

No Additional Files

More +

Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine

[PDF - 515.21 KB]

:

United States. Advisory Committee on Immunization Practices.

August 10, 2007 | MMWR. Morbidity and mortality weekly report. 2007; 56(31):794-5.

Description:

In January 2005, a quadrivalent meningococcal polysaccharide- protein conjugate vaccine (MCV4) (Menactra™, Sanofi Pasteur, Inc., Swiftwater, Pennsyl...

Status:

superseded

File Type:

[PDF - 515.21 KB]

File Type:

[PDF - 515.21 KB]
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease. MMWR 60 (40): 1391-1392.

[PDF - 64.63 KB]

:

United States. Advisory Committee on Immunization Practices.

October 14, 2011 | MMWR. Morbidity and mortality weekly report. 2011; 60(40):1391-2.

Description:

In April 2011, the Food and Drug Administration approved the use of a quadrivalent meningococcal conjugate vaccine (MenACWY-D) (Menactra, Sanofi Paste...

Status:

superseded

File Type:

[PDF - 64.63 KB]

File Type:

[PDF - 64.63 KB]
Control and prevention of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP).

[PDF - 351.06 KB]

:

United States. Advisory Committee on Immunization Practices.

February 14, 1997 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):1-10.

Description:

These recommendations update information regarding the polysaccharide vaccine licensed in the United States for use against disease caused by Neisseri...

Status:

superseded

File Type:

[PDF - 351.06 KB]

File Type:

[PDF - 351.06 KB]
Control and prevention of serogroup C meningococcal disease : evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP)

[PDF - 311.86 KB]

:

United States. Advisory Committee on Immunization Practices.

February 14, 1997 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1997; 46(RR-5):13-21.

Description:

Outbreaks of serogroup C meningococcal disease (SCMD) have been occurring more frequently in the United States since the early 1990s, and the use of v...

Status:

superseded

File Type:

[PDF - 311.86 KB]

File Type:

[PDF - 311.86 KB]
Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease

[PDF - 1.49 MB]

:

United States. Advisory Committee on Immunization Practices.

September 25, 2009 | MMWR. Morbidity and mortality weekly report. 2009; 58(37):1042-3.

Description:

The Advisory Committee on Immunization Practices (ACIP) recommends quadrivalent meningococcal conjugate vaccine, (MCV4) (Menactra, Sanofi Pasteur, Swi...

Status:

superseded

File Type:

[PDF - 1.49 MB]

File Type:

[PDF - 1.49 MB]
Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease--Advisory Committee on Immunization Practices (ACIP), 2011

[PDF - 72.15 KB]

:

United States. Advisory Committee on Immunization Practices.

August 11, 2011 | MMWR. Morbidity and mortality weekly report. 2011; 60(30):1018-9.

Description:

In January 2011, the Food and Drug Administration lowered the approval age range for use of MenACWY-CRM (Menveo, Novartis Vaccines and Diagnostics), a...

Status:

superseded

File Type:

[PDF - 72.15 KB]

File Type:

[PDF - 72.15 KB]
Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.

[PDF - 1.59 MB]

:

United States. Advisory Committee on Immunization Practices.

March 12, 2010 | MMWR. Morbidity and mortality weekly report. 2010; 59(9):273.

Description:

On February 19, 2010, the Food and Drug Administration (FDA) licensed a quadrivalent meningococcal conjugate vaccine, MenACWY-CRM (Menveo, Novartis Va...

Status:

superseded

File Type:

[PDF - 1.59 MB]

File Type:

[PDF - 1.59 MB]
Updated recommendations for use of meningococcal conjugate vaccines -- Advisory Committee on Immunization Practices (ACIP), 2010

[PDF - 313.07 KB]

:

United States. Advisory Committee on Immunization Practices.

January 28, 2011 | MMWR. Morbidity and mortality weekly report. 2011; 60(3):72-6.

Description:

On October 27, 2010, the Advisory Committee on Immunization Practices (ACIP) approved updated recommendations for the use of quadrivalent (serogroups ...

Status:

superseded

File Type:

[PDF - 313.07 KB]

File Type:

[PDF - 313.07 KB]
Report from the Advisory Committee on Immunization Practices (ACIP) : Decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4)

[PDF - 373.12 KB]

:

United States. Advisory Committee on Immunization Practices.

May 2, 2008 | MMWR. Morbidity and mortality weekly report. 2008; 57(17):462-5.

Description:

At its February 2008 meeting, the Advisory Committee on Immunization Practices (ACIP) decided not to recommend routine vaccination of children aged 2-...

Status:

superseded

File Type:

[PDF - 373.12 KB]

File Type:

[PDF - 373.12 KB]
Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

[PDF - 321.91 KB]

Personal Author:

Bilukha, Oleg ;

Rosenstein, Nancy E.

May 27, 2005 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-7

Description:

"In January 2005, a tetravalent meningococcal polysaccharide-protein conjugate vaccine ([MCV4] Menactra, manufactured by Sanofi Pasteur, Inc., Swiftwa...

Status:

superseded

File Type:

[PDF - 321.91 KB]

File Type:

[PDF - 321.91 KB]
Prevention and Control of Meningococcal Disease and Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) [2000–06]

[PDF - 179.37 KB]

Personal Author:

Rosenstein, Nancy E. ;

Perkins, Bradley A.

June 30, 2000 | MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-7):1-10.

Description:

This report summarizes and updates an earlier published statement issued by the Advisory Committee on Immunization Practices concerning the control an...

Status:

superseded

File Type:

[PDF - 179.37 KB]

File Type:

[PDF - 179.37 KB]

Prevention and control of meningococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Details:

Supporting Files

Related Documents

You May Also Like